Skip to main content
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
10.03
-0.19 (-1.86%)
At close: Jul 19, 2024, 4:00 PM
10.17
+0.14 (1.40%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $79.60M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $56.38M. In the year 2023, Vir Biotechnology had annual revenue of $86.18M.

Revenue (ttm)
$79.60M
Revenue Growth
-82.16%
P/S Ratio
17.14
Revenue / Employee
$135,603
Employees
587
Market Cap
1.36B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.25B
Indivior 1.12B
U.S. Physical Therapy 611.97M
Phreesia 373.67M
BioCryst Pharmaceuticals 355.40M
Dynavax Technologies 236.15M
Nurix Therapeutics 62.30M
Revenue Rankings

VIR News

More News